Evidence map›Paper›PMID 31486324›Full record

ArticleCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology2019

Storage Primes Erythrocytes for Necroptosis and Clearance.

William D McCaig, Alexa L Hodges, Matthew A Deragon, Robert J Haluska, Sheila Bandyopadhyay, Adam J Ratner, Steven L Spitalnik, Eldad A Hod, Timothy J LaRocca

Open access · goldAbstract read
In one paragraph

Article in Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Apoptosis and eryptosis: similarities and differences.Apoptosis : an international journal on programmed cell death · 2024
    Review
  5. Article
  6. Article
  7. Myricetin-induced suicidal erythrocyte death.Molecular biology reports · 2023
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

William D McCaigDepartment of Basic and Clinical Sciences, Albany College of Pharmacy and Health Sciences, Albany, NY, USA.
Alexa L HodgesDepartment of Basic and Clinical Sciences, Albany College of Pharmacy and Health Sciences, Albany, NY, USA.
Matthew A DeragonDepartment of Basic and Clinical Sciences, Albany College of Pharmacy and Health Sciences, Albany, NY, USA.
Robert J HaluskaDepartment of Basic and Clinical Sciences, Albany College of Pharmacy and Health Sciences, Albany, NY, USA.
Sheila BandyopadhyayDepartment of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA.
Adam J RatnerDepartment of Pediatrics and Microbiology, New York University School of Medicine, New York, NY, USA.
Steven L SpitalnikDepartment of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA.
Eldad A HodDepartment of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA.
Timothy J LaRoccaDepartment of Basic and Clinical Sciences, Albany College of Pharmacy and Health Sciences, Albany, NY, USA, Timothy.LaRocca@acphs.edu.
Albany College of Pharmacy and Health Sciences · USColumbia University Irving Medical Center · USNew York University · US

Funding

Mechanisms and outcomes of the hyperglycemic shift to necroptosis in myeloid cellsR15HL135675 · NHLBI · ALBANY COLLEGE OF PHARMACY · PI LAROCCA, TIMOTHY J · 2017 to 2021
$960k
National Heart, Lung, and Blood Institute (NHLBI) NIH R15-HL135675-01NHLBI NIH HHS R15 HL135675
6 · The paper itself

Abstract

BACKGROUND/

aimsLike nucleated cells, erythrocytes (red blood cells, RBCs) are capable of executing programmed cell death pathways. RBCs undergo necroptosis in response to CD59-specific pore-forming toxins (PFTs). The relationship between blood bank storage and RBC necroptosis was explored in this study.

methodsHuman RBCs were stored in standard blood bank additive solutions (AS-1, AS-3, or AS-5) for 1 week and hemolysis was evaluated in the context of necroptosis inhibitors and reactive oxygen species (ROS) scavengers. Activation of key factors including RIP1, RIP3, and MLKL was determined using immunoprecipitations and western blot. RBC vesiculation and formation of echinocytes was determined using phase-contrast microscopy. The effect of necroptosis and storage on RBC clearance was determined using a murine transfusion model.

resultsNecroptosis is associated with increased RBC clearance post-transfusion. Moreover, storage in AS-1, AS-3, or AS-5 sensitizes RBCs for necroptosis. Importantly, storage-sensitized RBCs undergo necroptosis in response to multiple PFTs, regardless of specificity for CD59. Storage-sensitized RBCs undergo necroptosis via NADPH oxidase-generated ROS. RBC storage led to RIP1 phosphorylation and necrosome formation in an NADPH oxidase-dependent manner suggesting the basis for this sensitization. In addition, storage led to increased RBC clearance post-transfusion. Clearance of these RBCs was due to Syk-dependent echinocyte formation.

conclusionStorage-induced sensitization to RBC necroptosis and clearance is important as it may be relevant to hemolytic transfusion reactions.

Indexed as

Adjuvants, ImmunologicAnimalsApoptosisBlood BanksBlotting, WesternCD59 AntigensCell DeathCells, CulturedErythrocytesHemolysisHumansMiceMice, Inbred C57BLMice, TransgenicNecrosisPhosphorylationAdjuvants, ImmunologicCD59 AntigensReactive Oxygen SpeciesApoptosisBlood bankCell deathClearanceEryptosisErythrocyteNecroptosisRed blood cellStorageSykTransfusion

Identifiers

PMID31486324
PMCPMC9897227
OpenAlexW2972877607

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.